According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.57. In 2022 the company made an earnings per share (EPS) of -$2.29 an increase over its 2021 EPS that were of -$4.85.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.57 | 12.23% |
2022 | -$2.29 | -52.81% |
2021 | -$4.85 | 193.97% |
2020 | -$1.65 |